Get started
Author

Athanasios Sachinidis

Observed name: Sachinidis, Athanasios
ORCID: 0000-0002-3309-6032
Observed ORCID: 0000-0002-3309-6032
OpenAlex ID: A5033309472
mRNA in the Context of Protein Replacement Therapy
2023 · Theofanis Vavilis, Eleni Stamoula, et al. · Pharmaceutics · 146
PDF
COVID-19 vaccines adverse events: potential molecular mechanisms
2023 · Malamatenia Lamprinou, Athanasios Sachinidis, et al. · Immunologic Research · 90
PDF
Age-Associated B Cells (ABCs) in the Prognosis, Diagnosis and Therapy of Systemic Lupus Erythematosus (SLE)
2020 · Athanasios Sachinidis, Konstantinos Xanthopoulos, et al. · Mediterranean Journal of Rheumatology · 56
PDF
COVID‐19 vaccination can occasionally trigger autoimmune phenomena, probably via inducing age‐associated B cells
2021 · Athanasios Sachinidis, Alexandros Garyfallos · International Journal of Rheumatic Diseases · 42
PDF
Double Negative (DN) B cells: A connecting bridge between rheumatic diseases and COVID-19?
2021 · Athanasios Sachinidis, Alexandros Garyfallos · Mediterranean Journal of Rheumatology · 31
Vitamin Effects in Primary Dysmenorrhea
2023 · Alkis Matsas, Athanasios Sachinidis, et al. · Life · 24
PDF
Subclinical atherosclerosis in systemic sclerosis and rheumatoid arthritis: a comparative matched-cohort study
2020 · Theodoros Dimitroulas, Pantelis Baniotopoulos, et al. · Rheumatology International · 19
Involvement of age-associated B cells in EBV-triggered autoimmunity
2022 · Athanasios Sachinidis, Alexandros Garyfallos · Immunologic Research · 11
PDF
Characterization of T-bet expressing B cells in lupus patients indicates a putative prognostic and therapeutic value of these cells for the disease
2025 · Athanasios Sachinidis, Maria Trachana, et al. · Clinical & Experimental Immunology · 10
Targeting T-bet expressing B cells for therapeutic interventions in autoimmunity
2024 · Athanasios Sachinidis, Malamatenia Lamprinou, et al. · Clinical & Experimental Immunology · 10
PDF
Biopharmaceuticals against substance use disorders – Present and future
2023 · Theofanis Vavilis, Eleni Stamoula, et al. · European Journal of Pharmacology · 6
Age-associated B cells and double-negative B cells: two sides of the same coin? The answer depends on the context
2026 · Malamatenia Lamprinou, Athanasios Sachinidis, et al. · Frontiers in Aging · 4
PDF
Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation
2024 · Theofanis Vavilis, Maria Louiza Petre, et al. · Cancers · 4
PDF
Investigating the Role of T-bet+ B Cells (ABCs/DN) in the Immunopathogenesis of Systemic Lupus Erythematosus
2023 · Athanasios Sachinidis, Maria Trachana, et al. · Mediterranean Journal of Rheumatology · 3
PDF
Rho-kinase inhibitors to deplete age-associated B cells in systemic autoimmunity
2023 · Athanasios Sachinidis, Alexandros Garyfallos · Immunology Letters · 1
Restoration of Fli1 expression as a potential therapeutic approach in Systemic Sclerosis: Effects on age-associated B cells
2025 · Athanasios Sachinidis, Malamatenia Lamprinou, et al. · Immunology Letters
Contradictory expression levels of FcγRIIB (CD32) on atypical-B cell populations in systemic sclerosis reflect immune system dysregulation
2025 · Athanasios Sachinidis, Malamatenia Lamprinou · Clinical Immunology
P119 T-bet+ B cells can serve as prognostic and therapeutic tools for human systemic lupus erythematosus
2024 · Athanasios Sachinidis, Maria Trachana, et al. · Lupus Science & Medicine
PDF
Omics and related recent technologies
2023 · Alexandra Ainatzoglou, Theofanis Vavilis, et al. · Elsevier eBooks
Next generation sequencing in toxicology
2023 · Theofanis Vavilis, Eleni Stamoula, et al. · Elsevier eBooks
Works count: 21
Citation count: 457
H-index: 10
I10-index: 10
Year
Topic
Type